Poster Presentations
Poster presentations showcasing the latest breakthroughs from students, early-career researchers and industry scientists.
Read More7th Edition · Upcoming
7th Annual Summit on Biopharmaceutical Product Development
Biologics 2027 The Global Convergence
Hosted by the Mumbai Biocluster in association with the Institute of Chemical Technology, Mumbai. Driving global convergence across the end-to-end biopharmaceutical lifecycle.
Summit begins in
--Days
--Hours
--Mins
--Secs
Date-
VenueMahatma Mandir Convention and Exhibition Centre, Gandhinagar, Gujarat
Biosimilars (mAbs) Multispecifics ADCs Vaccines Cell & Gene Therapy CAR-T Crispr Cas-9 AI × Biologics NAMs
About Biologics 2027
Driving Global Convergence
The 7th Annual Summit on Biopharmaceutical Product Development — Biologics 2027, hosted by the Mumbai Biocluster in association with the Institute of Chemical Technology, Mumbai, is designed around a single imperative: Driving Global Convergence across the end-to-end biopharmaceutical lifecycle.
As the global biopharma landscape pivots toward the $320 Billion biosimilars opportunity, the summit is powered by the Biosimilar Golden Decade and Mission 100 Biologics under India’s Biopharma SHAKTI initiative.
$320 BillionGlobal biosimilars opportunity
Biosimilar Golden Decade
The momentum shaping India’s role in global biosimilar development.
Mission 100 Biologics
An ambitious goal under India’s Biopharma SHAKTI initiative.
Agenda Highlights 2027
Four plenary panels open the programme, followed by sixteen sessions across science, regulation, manufacturing and investment.
4Plenary panels
16Sessions
9Topic areas
Plenary Panel
- ‘Pharmacy of the World’ to ‘Biotech Powerhouse of the World’: Journey towards value-driven novel biologics, bioprocess intensification, and AI biofoundries
- Golden Decade for Biosimilars, Opportunity, Ambition and Strategic Disruption
- Navigating Biosimilar Market from out-licensing, commercial partnership & multi node CDMO infrastructure
- Policies, initiatives & Strategies to accelerate Mission 100 biologics
All Sessions
- AI in drug discovery & next gen PK/PD modelling
- Predictive Accuracy vs. Regulatory Proof: Should Biopharma Pivot to Physics-Informed AI?
- Building India’s Vaccine Manufacturing Surge Capacity (Localizing Resins, Media, and Single-Use Technologies for Indian Biomanufacturing)
- Single Use Technology, development, leeching issues, COGS.
- Unlocking the Potential of Next-Gen ADCs: From CMC to Commercial Biomanufacturing
- AI-Guided Antibody Optimisation for Indian Biosimilars and Novel Biologics
- Translating Ex Vivo & In Vivo CRISPR Models for High-Burden Indian Diseases
- AI-driven bioprocess digital twins with Quality-by-design
- The IP Engine: Aligning Science, Strategy, and Exclusivity Across the Biologics Lifecycle
- Accelerating Biologics Development Through Precision Host Engineering and Characterization
- Big Data Analytics is Reshaping Clinical Development
- Engineering Next-Generation Facilities for Commercial-Grade ADCs
- Rare Disease Biologics: Orphan Drug Pathways, Clinical Trial Design for Small N & India’s Unmet Need
- In vivo gene therapy
- High-Throughput Antibody Screening using Tagged Bio-analytical Binding Assays or Biophysical Molecular Interaction Technologies.
- Democratizing Access to Cell and Gene Therapies: Innovation, Affordability, and Global Impact
Key Features of Biologics 2027
Five pillars built to move ideas from bench to product.
Four Parallel Scientific Tracks & On-Event Workshops
Four dedicated parallel scientific tracks and on-event workshops covering advanced topics, led by global leaders.
Read MoreBRIDGE
From Bench to Product: Crossing the Valley of Death through Industry-Academia Collaboration.
Visit BRIDGEBiopharma Exhibition
Showcase your emerging tech at the Biopharma Exhibition for high-impact networking.
Read MoreOrganizing Committee
NCNarendra Chirmule
Co-founder & CEO
SymphonyTech Biologics
DPDhananjay Patankar
Independent Biopharma Consultant
Former VP, Syngene
PKPrabuddha Kundu
Co-founder & MD
Premas Biotech
RBRahul Bhambhure
Senior Scientist
CSIR-NCL, Pune
SGSanjeev Gupta
Senior VP & Head, Biosimilars
Ipca Laboratories Ltd.
DPDarshan Parekh
CEO
Amar Biosystems
Speakers 2027
JBJoanna T. Brougher
Owner & Principal
BioPharma Law Group, PLLC
GSGaurav Sahay
Professor & Interim Chair, Pharmaceutical Sciences; Co-Director, CIDDI
Oregon State University, College of Pharmacy
TATaruna Arora, PhD
Chief Scientific Officer
New Co
MPMrunal Monica Phadnis
Senior VP, Head of Clinical Operations
Acrivon Therapeutics
DBDebaditya Bhattacharya*
Vice President, CMC
Myrtelle
KVKalpit Vora
Distinguished Investigator
Merck
NJNaresh Jain
Founder & CEO
NJ Bio
BBBhushan Bhonde
Visiting Professor of Computational Biology
University of Suffolk
KMKrishna Mallela*
Professor
University of Colorado Anschutz Medical Campus
MZMarkus Zettl
Head of Discovery – Therapeutic Lead, Immuno-Oncology & CGT
Biological E. Ltd
EWDr. Elena Wolff-Holz
Chief Medical Officer
Biocon Biologics, Germany
*Subject to modification
A Look Back
Biologics 2026 Success Story
Biologics 2026 brought global biopharma leaders to the shores of Goa for high-impact conversations on the future of biologics and biosimilar development.
- Goa, India
- 6th Annual Edition
Lamp lighting 
On stage 
Networking 
Group photo
The 6th Annual Biologics Conference and Workshop on Biopharmaceutical Technology and Manufacturing, held on January 21-23, 2026, in Goa, India, was a resounding success. Bringing together global leaders, policymakers and researchers, the conference provided a platform for sharing groundbreaking research, fostering collaborations and discussing the future of biopharmaceuticals.
The Agenda Covered
- India’s Playbook for Novel Biologics R&D
- Biopharma Journey: Leadership And Vision In Action
- Clinical Development & Regulatory Strategy Regulatory
- Future Biomanufacturing Platforms Biomanufacturing
- Digital Bioprocessing & AI Integration Digital Bioprocessing
- Upstream Bioprocessing Upstream
- Breakthroughs in Emerging Modalities CGT
- Downstream Process Enablers Downstream
- Strategies For Analytical Characterization Analytical
Key Highlights That Made It Memorable
- Insightful Scientific Sessions & Panel DiscussionsA landmark session with US FDA leaders explored the future of biosimilar manufacturing, alongside podcasts and expert panels.
- Innovative Poster Presentations75+ posters showcased the latest research from students, early-career researchers and industry scientists.
- Meaningful Networking & Collaborations800+ delegates connected across science, policy and industry, forging partnerships for what comes next in biopharma.
- Startup Showcase SuccessPromising startups and young innovators pitched breakthrough ideas to investors and industry leaders.
- Closed-Door Round Table DiscussionsLeadership roundtables brought key stakeholders together for candid, cross-sector dialogue.
Biologics 2026 Impact
The reach and influence of our previous summit, in numbers.
- 75+Research Posters
- 150+Speakers
- 800+Attendees
- 80+Start-ups
- 50+Exhibitors
Past Speakers
Promoting Inclusivity in STEM — an Indian National Science Academy Women Associate (IWA) and Institute of Chemical Technology initiative.
Moderator
VR
VRMs. Viveka Roychowdhury
Editor
Express Pharma, Express Healthcare & In Imaging
MMDr. Manisha R. Madkaikar
Scientist G and Director
ICMR-CRMCH
GSDr. Geetanjali Sachdeva
Director & Scientist G
NIRRCH
What Our Past Speakers Said
The conference has provided a wonderful networking opportunity to learn more about the Indian biotech ecosystem, which is an amazing growth opportunity. I had the pleasure of speaking on a panel and giving a talk about cell-based assays.
Dr. Dan MamelakFounder & President Of Custom BiologicsIt’s just been an amazing conference so far. I am thrilled to see the level of energy here and looking forward to interacting with the audience.
Dr. Hari PujarOperating Partner, Founding President of Mirai Bio, & COO Tessera TherapeuticsPartners 2026
With gratitude to the organizations that stood with us at Biologics 2026.
Key Sponsors
Media Partners
Frequently Asked Questions
Quick answers about Biologics 2027 and the previous edition.
What is Biologics 2027?
Biologics 2027: The Global Convergence is the 7th Annual Summit on Biopharmaceutical Product Development, hosted by the Mumbai Biocluster in association with the Institute of Chemical Technology (ICT), Mumbai. It brings together global leaders, innovators, regulators and bioprocess executives across the end-to-end biopharmaceutical lifecycle: discovery and development, manufacturing and commercialization.
When and where is Biologics 2027 held?
Biologics 2027 takes place on 28-30 January 2027 at the Mahatma Mandir Convention and Exhibition Centre, Gandhinagar, Gujarat, India.
Who organizes the summit?
The summit is hosted by the Mumbai Biocluster in association with the Institute of Chemical Technology, Mumbai. The convener is Dr. Ratnesh Jain, Associate Professor at ICT Mumbai and Founder and Director of Mumbai Biocluster.
What topics will Biologics 2027 cover?
Topics include biosimilars (mAbs), multispecifics, ADCs, vaccines, cell and gene therapy, CAR-T, Crispr Cas-9, AI in biologics and NAMs. The agenda opens with four plenary panels followed by sixteen sessions across science, regulation, manufacturing and investment.
What can I take part in at the summit?
The summit features four parallel scientific tracks with on-event workshops, BRIDGE for industry-academia collaboration, the Biopharma Exhibition, Poster Presentations for students, early-career researchers and industry scientists, and BioPitch for young innovators.
How can I register, present, exhibit or partner?
For registration, speaking, poster, exhibition and partnership enquiries, please reach the programme team through the Contact Us page, or write to ashwini.patil@mumbaibiocluster.org or head.programs@mumbaibiocluster.org. You can also call +91 81697 84334 or +91 81697 84314.
What happened at the previous edition, Biologics 2026?
The 6th Annual Biologics Conference and Workshop on Biopharmaceutical Technology and Manufacturing was held on 21-23 January 2026 in Goa, India. It brought together 800+ attendees, 150+ speakers, 75+ research posters, 80+ start-ups and 50+ exhibitors.
Can I see the agenda of the previous edition?
Yes. Use the View Previous Year Agenda button on this page, enter your name, organization and email, and the Biologics 2026 agenda will open.
See you in Gandhinagar
Be Part of Biologics 2027
28-30 January 2027 · Mahatma Mandir Convention & Exhibition Centre, Gandhinagar, Gujarat
Dr. Ratnesh Jain
Convener
Associate Professor, ICT, Mumbai
Founder & Director, Mumbai Biocluster
#BSW2027